Stock Earnings

Question 1

Quels sont les états financiers clés de China Shineway Pharmaceutical Group Ltd ?

Accepted Answer

Selon le dernier état financier (Form-10K), China Shineway Pharmaceutical Group Ltd a un total d'actifs de $10,041, un bénéfice net profit de $840

Question 2

Quels sont les ratios financiers clés pour CSWYF ?

Accepted Answer

Le ratio de liquidité de China Shineway Pharmaceutical Group Ltd est 3.9, la marge nette est 22.23, les ventes par action sont de $5.

Question 3

Comment les revenus de China Shineway Pharmaceutical Group Ltd sont-ils répartis par segment ou géographie ?

Accepted Answer

China Shineway Pharmaceutical Group Ltd largest revenue segment is Injections, at a revenue of 1,374,777,459 in the most earnings release.For geography, China including Hong Kong is the primary market for China Shineway Pharmaceutical Group Ltd, at a revenue of 4,096,244,475.

Question 4

China Shineway Pharmaceutical Group Ltd est-elle rentable ?

Accepted Answer

yes, selon les derniers états financiers, China Shineway Pharmaceutical Group Ltd a un bénéfice net profit de $840

Question 5

China Shineway Pharmaceutical Group Ltd a-t-elle des passifs ?

Accepted Answer

yes, China Shineway Pharmaceutical Group Ltd a un passif de 2,574

Question 6

Combien d'actions en circulation China Shineway Pharmaceutical Group Ltd a-t-elle ?

Accepted Answer

China Shineway Pharmaceutical Group Ltd a un total d'actions en circulation de 827

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	3,344	3,778	4,516	3,950	3,223	2,655
Revenue Growth (YoY)	-20%	-16%	14%	23%	21%	-2%
Cost of Revenue	890	946	1,122	1,012	813	667
Gross Profit	2,453	2,831	3,394	2,938	2,410	1,987
Selling, General & Admin	1,700	1,895	2,313	2,107	1,763	1,458
Research & Development	106	100	110	117	112	99
Operating Expenses	1,638	1,817	2,260	2,111	1,773	1,472
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	1,058	1,145	1,240	917	720	395
Income Tax Expense	230	305	270	194	163	99
Net Income	828	840	969	722	556	295
Net Income Growth	-25%	-13%	34%	30%	88%	-41%
Shares Outstanding (Diluted)	755.4	755.4	755.4	755.4	755.14	756.74
Shares Change (YoY)	0%	0%	0%	0%	0%	-3%
EPS (Diluted)	1.09	1.11	1.28	0.95	0.73	0.38
EPS Growth	-25%	-13%	34%	30%	89%	-39%
Free Cash Flow	799	823	788	980	609	572
Free Cash Flow Per Share	1.05	1.08	1.04	1.29	0.8	0.75
Gross Margin	73.35%	74.93%	75.15%	74.37%	74.77%	74.83%
Operating Margin	24.34%	26.81%	25.08%	20.91%	19.73%	19.39%
Profit Margin	24.76%	22.23%	21.45%	18.27%	17.25%	11.11%
Free Cash Flow Margin	23.89%	21.78%	17.44%	24.81%	18.89%	21.54%
EBITDA	--	1,081	1,310	1,011	818	723
EBITDA Margin	--	28.61%	29%	25.59%	25.38%	27.23%
D&A For EBITDA	--	68	177	185	182	208
EBIT	814	1,013	1,133	826	636	515
EBIT Margin	24.34%	26.81%	25.08%	20.91%	19.73%	19.39%
Effective Tax Rate	21.73%	26.63%	21.77%	21.15%	22.63%	25.06%

China Shineway Pharmaceutical Group Ltd (CSWYF) Price

CSWYF Stock Price Chart

CSWYF Income

Follow-Up Questions